Assertio Therapeutics Total Debt vs. Total Asset
| ASRT Stock | USD 0.79 0.01 1.25% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.32 | 0.95 |
|
|
For Assertio Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Assertio Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Assertio Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Assertio Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Assertio Therapeutics over time as well as its relative position and ranking within its peers.
Assertio |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Earnings Share (4.94) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets |
The market value of Assertio Therapeutics is measured differently than its book value, which is the value of Assertio that is recorded on the company's balance sheet. Investors also form their own opinion of Assertio Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Assertio Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assertio Therapeutics' market value can be influenced by many factors that don't directly affect Assertio Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assertio Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assertio Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assertio Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assertio Therapeutics Total Asset vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Assertio Therapeutics's current stock value. Our valuation model uses many indicators to compare Assertio Therapeutics value to that of its competitors to determine the firm's financial worth. Assertio Therapeutics is rated below average in total debt category among its peers. It is rated below average in total asset category among its peers fabricating about 7.00 of Total Asset per Total Debt. At this time, Assertio Therapeutics' Total Assets are comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Assertio Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Assertio Total Debt vs. Competition
Assertio Therapeutics is rated below average in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 33.14 Billion. Assertio Therapeutics adds roughly 40.91 Million in total debt claiming only tiny portion of equities under Health Care industry.
Assertio Total Asset vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Assertio Therapeutics |
| = | 40.91 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Assertio Therapeutics |
| = | 286.42 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Assertio Total Asset Comparison
Assertio Therapeutics is currently under evaluation in total asset category among its peers.
Assertio Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Assertio Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Assertio Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Assertio Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Assertio Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -10.7 M | -10.1 M | |
| Operating Income | -219.2 M | -208.2 M | |
| Net Loss | -298.7 M | -283.8 M | |
| Income Tax Expense | 70.1 M | 73.6 M | |
| Income Before Tax | -228.6 M | -217.2 M | |
| Total Other Income Expense Net | -9.5 M | -9 M | |
| Net Income Applicable To Common Shares | 98.7 M | 103.6 M | |
| Net Loss | -298.7 M | -283.8 M | |
| Non Operating Income Net Other | 34.9 M | 36.6 M | |
| Interest Income | 49 M | 51.4 M | |
| Net Interest Income | -15.3 M | -16.1 M | |
| Change To Netincome | -59.5 M | -56.5 M | |
| Net Loss | (4.21) | (4.00) | |
| Income Quality | (0.17) | (0.16) | |
| Net Income Per E B T | 1.18 | 1.19 |
Assertio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Assertio Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Assertio Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Assertio Therapeutics' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Assertio Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Use Investing Themes to Complement your Assertio Therapeutics position
In addition to having Assertio Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.